These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9043933)

  • 1. Immunomodulatory assays to study structure-activity relationships of thalidomide.
    Shannon EJ; Morales MJ; Sandoval F
    Immunopharmacology; 1997 Jan; 35(3):203-12. PubMed ID: 9043933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide suppressed IL-1beta while enhancing TNF-alpha and IL-10, when cells in whole blood were stimulated with lipopolysaccharide.
    Shannon E; Noveck R; Sandoval F; Kamath B
    Immunopharmacol Immunotoxicol; 2008; 30(3):447-57. PubMed ID: 18668392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production.
    Marriott JB; Westby M; Cookson S; Guckian M; Goodbourn S; Muller G; Shire MG; Stirling D; Dalgleish AG
    J Immunol; 1998 Oct; 161(8):4236-43. PubMed ID: 9780198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-alpha.
    Shannon EJ; Sandoval F; Krahenbuhl JL
    Immunopharmacology; 1997 Apr; 36(1):9-15. PubMed ID: 9129992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10.
    Mazzoccoli L; Cadoso SH; Amarante GW; de Souza MV; Domingues R; Machado MA; de Almeida MV; Teixeira HC
    Biomed Pharmacother; 2012 Jul; 66(5):323-9. PubMed ID: 22770990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+ cells in their blood.
    Shannon E; Aseffa A; Pankey G; Sandoval F; Lutz B
    Immunopharmacology; 2000 Feb; 46(2):175-9. PubMed ID: 10647875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat.
    Fernández-Martínez E; Morales-Ríos MS; Pérez-Alvarez V; Muriel P
    Biochem Pharmacol; 2004 Oct; 68(7):1321-9. PubMed ID: 15345321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors.
    Chaulet C; Croix C; Alagille D; Normand S; Delwail A; Favot L; Lecron JC; Viaud-Massuard MC
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1019-22. PubMed ID: 21215621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective down-regulation of T cell- and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone.
    Rowland TL; McHugh SM; Deighton J; Ewan PW; Dearman RJ; Kimber I
    Immunol Lett; 1999 Jun; 68(2-3):325-32. PubMed ID: 10424439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of IL-12 production by thalidomide.
    Moller DR; Wysocka M; Greenlee BM; Ma X; Wahl L; Flockhart DA; Trinchieri G; Karp CL
    J Immunol; 1997 Nov; 159(10):5157-61. PubMed ID: 9366446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide inhibited the synthesis of IgM and IgG whereas Thalidomide+Dexamethasone and Dexamethasone alone acted as co-stimulants with pokeweed and enhanced their synthesis.
    Shannon EJ; Sandoval F
    Int Immunopharmacol; 2010 Apr; 10(4):487-92. PubMed ID: 20123041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of LPS-, PHA- and M. tuberculosis-mediated cytokine production by pentoxifylline and thalidomide.
    van Crevel R; Vonk AG; Netea MG; Kullberg BJ; van der Meer JW
    Eur Cytokine Netw; 2000 Dec; 11(4):574-9. PubMed ID: 11125299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biological response modifiers derived from thalidomide.
    Hashimoto Y
    Curr Med Chem; 1998 Jun; 5(3):163-78. PubMed ID: 9562600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of de novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy.
    Shannon EJ; Miranda RO; Morales MJ; Hastings RC
    Scand J Immunol; 1981; 13(6):553-62. PubMed ID: 7031850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thalidomide on the expression of TNF-alpha m-RNA and synthesis of TNF-alpha in cells from leprosy patients with reversal reaction.
    Tadesse A; Abebe M; Bizuneh E; Mulugeta W; Aseffa A; Shannon EJ
    Immunopharmacol Immunotoxicol; 2006; 28(3):431-41. PubMed ID: 16997792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells.
    Shannon EJ; Sandoval F
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):59-72. PubMed ID: 8683039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical stabilities and biological activities of thalidomide and its N-alkyl analogs.
    Goosen C; Laing TJ; du Plessis J; Goosen TC; Rao TB; Flynn GL
    Pharm Res; 2002 Aug; 19(8):1232-5. PubMed ID: 12240951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production.
    Miyachi H; Azuma A; Hioki E; Iwasaki S; Kobayashi Y; Hashimoto Y
    Biochem Biophys Res Commun; 1996 Jul; 224(2):426-30. PubMed ID: 8702405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by thalidomide: systematic review of the literature and of unpublished observations.
    Zwingenberger K; Wnendt S
    J Inflamm; 1995-1996; 46(4):177-211. PubMed ID: 8878794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs.
    Schafer PH; Gandhi AK; Loveland MA; Chen RS; Man HW; Schnetkamp PP; Wolbring G; Govinda S; Corral LG; Payvandi F; Muller GW; Stirling DI
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1222-32. PubMed ID: 12649301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.